Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127466941 | 12746694 | 1 | I | 20160331 | 20160911 | 20160915 | 20160915 | EXP | PHHY2016DE127114 | NOVARTIS | 0.00 | E | F | Y | 0.00000 | 20160915 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127466941 | 12746694 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
| 127466941 | 12746694 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 127466941 | 12746694 | 3 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 127466941 | 12746694 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 127466941 | 12746694 | 5 | C | HCT | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 OT, UNK | 0 | ||||||||||
| 127466941 | 12746694 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 127466941 | 12746694 | 7 | C | CARBIMAZOL | CARBIMAZOLE | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 127466941 | 12746694 | 8 | C | LITALIR | HYDROXYUREA | 1 | Unknown | 2000 MG, UNK | Y | 0 | 2000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127466941 | 12746694 | 1 | Chronic myeloid leukaemia |
| 127466941 | 12746694 | 2 | Product used for unknown indication |
| 127466941 | 12746694 | 3 | Product used for unknown indication |
| 127466941 | 12746694 | 4 | Product used for unknown indication |
| 127466941 | 12746694 | 5 | Product used for unknown indication |
| 127466941 | 12746694 | 6 | Product used for unknown indication |
| 127466941 | 12746694 | 7 | Product used for unknown indication |
| 127466941 | 12746694 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127466941 | 12746694 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127466941 | 12746694 | 1 | 20160315 | 0 | ||
| 127466941 | 12746694 | 2 | 20160217 | 0 | ||
| 127466941 | 12746694 | 3 | 20160129 | 0 | ||
| 127466941 | 12746694 | 4 | 20160129 | 0 | ||
| 127466941 | 12746694 | 5 | 20160129 | 0 | ||
| 127466941 | 12746694 | 6 | 20160129 | 0 | ||
| 127466941 | 12746694 | 7 | 20160129 | 0 | ||
| 127466941 | 12746694 | 8 | 20160217 | 20160311 | 0 |